Median Technologies Records Its Eighth Consecutive Quarter of Revenue Growth
SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News:
Median Technologies (Paris:ALMDT)(ALMDT), The Imaging Phenomics Company®, today provided an update on its performance for Q3, 2020 (unaudited figures).
Revenue totalled €3.5m in Q3 2020 vs. €2.3m in Q3 2019, a 50% increase. Revenue growth was up 12% compared to Q2 2020. The company has experienced a steady increase in its quarterly revenue for eight consecutive quarters. At the end of Q3 2020, cumulative revenue for the first three quarters of 2020 was €9.4m, higher than that generated throughout the entirety of 2019 (€9m). Revenues are entirely generated by the iCRO1 business unit, which provides imaging solutions and services for oncology trials.